Pharma Journalist - Page 887 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Novartis expanded commercialization agreement with Amgen for AMG 334 (erenumab)

UBP selects GE Flexfactory platform to new facility in Hsinchu Industrial park

Feinstein Institute and TheraSource Receive Grant to Test Novel Sepsis Therapy

NGM Bio’s NGM282 succeeds in nonalcoholic steatohepatitis phase 2 trial

Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib

Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara (sarilumab)

Recipharm delivers first serialised batch to Saudi Arabia

Top 5 Reasons to Outsource Your Site Payments Process

J&J buys 3D-printing tech to create bone-healing implants

Novartis’s CTL019 receives FDA Breakthrough Therapy designation